The composition of the platelet cytoskeleton following activation by ADP: Effects of various agents that modulate platelet function

Platelets

Volumn 7, Issue 3, 1996, Pages 159-168

  May, J A ^a   Glenn, J R ^a   Spangenberg, P ^b   Heptinstall, S ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN BINDING PROTEIN; ADENOSINE DIPHOSPHATE; ALPHA ACTIN; FIBRINOGEN; MAGNESIUM CHLORIDE; MYOSIN; TRITON X 100;

ARTICLE; CYTOSKELETON; GLANZMANN DISEASE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SOLUBILIZATION; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION;

EID: 0029831108     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.3109/09537109609023575     Document Type: Article

References (15)

1. Lages B, Weiss H J. Dependence of human platelet functional responses on divalent cations: aggregation and secretion in heparin and hirudin anticoagulated platelet-rich plasma and the effects of chelating agents. Thromb Haemost 1081; 45: 173-9.
2. Fox J E B. The platelet cytoskeleton. Thromb Haemost 1993; 70: 884-93.
3. May JA, Heptinstall S, Spangenberg P. Changes in the composition of the platelet cytoskeleton in response to ADP: effects of MK-852 and ARL 66096. Blood Coag Fibrinolysis 1996; 7: 221-4.
4. Yuan A S, Hand E L, Hichens M, Olah T V, Barrish A, Fernandez-Metzler C, Gilbert J D. Determination of MK-852, a new fibrinogen receptor antagonist, in plasma and urine by radio-immunoassay. J Pharm Biomed Anal 1993; 11: 427-34.
5. 2T-purinoceptors. Br J Pharmacol 1994; 113: 1057-63.
6. Sanderson H M, Heptinstall S, Vickers J, Lösche W. Studies on the effects of agonists and antagonists on platelet shape change and platelet aggregation in whole blood. Blood Coag Fibrinolysis 1996; 7: 245-8.
7. Fujimura K, Fujimoto T, Takemoto M, Oda K, ShimomuraT, Maehama S, Kuramoto A. Analysis of platelet cytoskeleton assembly during platelet activation in Hermansky-Pudlak syndrome and thrombasthenia. Thromb Haemost 1990; 63: 103-11.
8. Fox J E B, Boyles J K, Berndt M C, Steffen P K, Anderson L K. Identification of a membrane skeleton in platelets. J Cell Biol 1988; 106: 1525-38.
9. Cachet C, Cattaneo M, Ohlman P, Hechler B, Lecchi A, Chevalier J, Cassel D, Mannucci P M, Cazenave J P. Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors. Br J Haematol 1995; 91: 434-44.
10. Hughes A, Tonks R S. Magnesium, adenosine diphosphate and blood platelets. Nature 1966; 210: 107-7.
11. Hermann R G, Lacefield W B, Crowe V G. Effect of ionic calcium and magnesium on human platelet aggregation. Proc Soc Exp Biol Med 1970; 135: 100-3.
12. Heptinstall S. The use of a chelating ion-exchange resin to evaluate the effects of the extracellular calcium ion concentration on adenosine disphosphate induced aggregation of human blood platelets. Thromb Haemostas 1976; 36(i): 208-20.
13. +2. Semin Thromb Haemostas 1995; 2: 137-45.
14. Hardy E, Heptinstall S, Rubin P C, Horn E H. Effects of raised extracellular magnesium on platelet reactivity. Platelets 1995; 6: 346-53.
15. Gawaz M, Ott I, Reininger A J, Neumann F-J. Effects of magnesium on platelet aggregation and adhesion. Thromb Haemostas 1995; 72: 912-8.